TABLE III.
No. | Bias | Description |
1 | Regulatory | Resulting from the inclusion of clinical studies of nonapproved U.S. products (products not approved may provide a negative bias) |
2 | Historical | Resulting from the comparison of clinical trials over decades, which may have led to the exclusion of studies not meeting current practices and thereby may not include studies of the first approved products |
3 | Effectiveness | Resulting from the exclusion of studies utilizing validated outcome measures at the time of design but not using the currently accepted or adopted outcome measures or methodology (excludes earlier studies) |
4 | Control | Resulting from the failure to distinguish true placebo controls from active comparators (saline solution injections) |